OR WAIT null SECS
February 27, 2020
If approved, the therapy may become the first-choice treatment for relapsing multiple sclerosis patients and will be the first B-cell therapy that can be self-administered using an autoinjector pen.
February 20, 2020
The companies aim to develop novel cell therapies for treating multiple cancers.
February 10, 2020
New funding brings competitors, and a leading healthcare products distributor, into the standardization effort.
February 06, 2020
The new facility includes six classified environment rooms with space to expand.
Contract partners must help innovators, especially smaller and virtual companies, consider manufacturability as early as possible in development. This requires focusing on technical and operational performance, as well as cost.
February 01, 2020
As cell and gene therapies become more prominent, industry is seeking the expertise and capabilities of outsourcing partners to ensure success.
The need for manufacturing speed inspires contract manufacturers to explore advanced processing technologies.
January 29, 2020
The new facility, to be operated under the newly formed CDMO, The Center for Breakthrough Medicines, will be located in King of Prussia, PA, and will increase manufacturing capacity for cell and gene therapies.
January 23, 2020
The new course is directed at analyzing the skills gap in the manufacture of cell and gene therapies as they progress toward manufacturing at scale.
January 22, 2020
The new company will work to provide the manufacturing technologies and processes needed to develop and commercialize new cell and gene therapies through individual company products and expertise.